HLN News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

HL

Mkt Cap

$44.53B

Volume

17.12M

Next Earnings

October 29th

Loading chart

HL

HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)

HLN

Pay with—

Available Balance0.00

HL

Mkt Cap

$43.71B

Volume

17.12M

Next Earnings

October 29th

Chart Financials Earnings News About Dividends Insider Filings

Prediction: These 3 Dividend Stocks Will Raise Their Payouts No Matter What the Market DoesThe article identifies three dividend stocks with strong fundamentals and resilient business models that are likely to continue raising payouts through economic downturns: WD-40 Company with 40 years of uninterrupted dividends backed by an iconic product with minimal competition, Energizer Holdings yielding 5.9% with essential consumer products, and Haleon with a conservative payout policy and health brands used by over a billion consumers worldwide.The Motley Fool · Oct 14, 2026

LCUT or HLN: Which Is the Better Value Stock Right Now?In a comparison of two Consumer Products - Discretionary stocks, Lifetime Brands (LCUT) emerges as the better value investment option compared to Haleon PLC Sponsored ADR (HLN). LCUT holds a Zacks Rank #1 (Strong Buy) with superior valuation metrics including a forward P/E of 4.05 versus HLN's 16.23, a PEG ratio of 0.29 versus 2.05, and a P/B ratio of 0.88 versus 1.84. LCUT also earned a Value grade of A compared to HLN's C grade.Zacks Investment Research · Sep 11, 2026

Dietary Supplements Market to Cross USD 187 Bn by 2031 as Gummies, Liquids, and Functional Formats Gain Traction, 2026 Mordor Intelligence ReportThe global dietary supplements market is projected to grow from USD 151.82 billion in 2026 to USD 187.22 billion by 2031 at a CAGR of 4.28%. Growth is driven by preventive healthcare adoption, aging populations, and shifting consumer preferences toward convenient formats like gummies and liquids. Asia-Pacific leads market share, while clean-label and personalized nutrition solutions are reshaping the industry.GlobeNewswire Inc. · Jan 23, 2026

Pfizer Offloads Its Last 7% Stake In Consumer Health Haleon For Over $3 BillionPfizer has sold its remaining 7.3% stake in Haleon for $3.1 billion, fully exiting its position in the company. Haleon expects 2025 organic revenue growth of 4% to 6%, with stronger performance in the second half.Benzinga · Mar 19, 2025

Sensodyne Toothpaste Maker Haleon Expects Profit To Be Weighted Towards Second Half Of 2025Haleon, the maker of Sensodyne toothpaste, reported a 0.6% decline in revenue for 2024 but expects 4-6% organic revenue growth in 2025, with stronger performance in the second half of the year. The company faces foreign exchange headwinds that may impact revenue and profit.Benzinga · Feb 27, 2025

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement BusinessDr Reddy's Laboratories reported a 16% increase in Q3 revenue, driven by its newly acquired Nicotine Replacement Therapy (NRT) portfolio and growth in emerging markets. The company's global generics revenue grew 17% year-over-year, with 7% growth excluding NRT contributions.Benzinga · Jan 23, 2025

What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?Pfizer is expected to provide its 2025 financial guidance on Tuesday. Goldman Sachs projects Pfizer's 2025 EPS to be higher than consensus, driven by strong Paxlovid sales, though Vyndaqel forecast misses consensus.Benzinga · Dec 16, 2024

Pediatric Oral Care Market Size, Trends, Opportunities and Forecast 2020-2030 with Competitive Analysis of Leading Players Such as Colgate-Palmolive, Unilever, Church & Dwight, Amway and HaleonThe global pediatric oral care market is expected to grow significantly due to rising awareness of early oral hygiene and increasing prevalence of dental issues in children. Demand for specialized products, including toothbrushes, toothpaste, and dental floss, is driving market expansion.GlobeNewswire Inc. · Nov 1, 2024

3 Factors That Make Pfizer's Ultra-High-Yield Dividend Safer Than You Might ThinkPfizer's COVID-19 products continue to generate significant cash flow, helping bolster the company's dividend. Pfizer's ability to monetize assets and its new product pipeline also contribute to the safety of its ultra-high-yield dividend.The Motley Fool · Oct 31, 2024

4 Reasons Pfizer Could Be a Value Play You Can't MissPfizer's stock has fallen over 60% since its peak during the pandemic, but the company is showing signs of recovery with revenue growth and a robust drug pipeline. The stock is trading at a value with a high dividend yield, making it an attractive investment opportunity.Investing.com · Oct 8, 2024

to start trading

HL

HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)

HLN

Pay with—

Available Balance0.00

Your PositionYou don't own any HLN yet.

Related Tickers

Earnings

Dividends

Last · Aug 14Semi-annual

Amount$0.0640

Yield1.92%

Annual$0.20